Extensive in vivo and in vitro studies, including large-scale ChIP-seq, RNAseq, and scRNA-seq, have revealed PRRX1's role as a lineage-specific TF of a subset of myCAFs, linked to cancer promotion and progression. Here, TF is linked to cancer.